Attenuated fusogenicity and pathogenicity of SARS-CoV-2 Omicron variant
2022 · Nature · 740 citations
https://doi.org/10.1038/s41586-022-04462-1
Y
Yasuko Orba
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
203
Papers
7.6K
Citations
42
h-index
118
i10-index
Yasuko Orba is an academic researcher from Sapporo International University. The author has contributed to research in topics: Mosquito-borne diseases and control & Viral Infections and Vectors & SARS-CoV-2 and COVID-19 Research. The author has an h-index of 42, co-authored 173 publications.
ORCID: 0000-0001-9910-3912Papers by this author
worksGold Nanoparticles as a Vaccine Platform: Influence of Size and Shape on Immunological Responses <i>in Vitro</i> and <i>in Vivo</i>
2013 · ACS Nano · 618 citations
https://doi.org/10.1021/nn3057005
Discovery of S-217622, a Noncovalent Oral SARS-CoV-2 3CL Protease Inhibitor Clinical Candidate for Treating COVID-19
2022 · Journal of Medicinal Chemistry · 566 citations
https://doi.org/10.1021/acs.jmedchem.2c00117
A novel nairovirus associated with acute febrile illness in Hokkaido, Japan
2021 · Nature Communications · 102 citations
https://doi.org/10.1038/s41467-021-25857-0
TMPRSS11D and TMPRSS13 Activate the SARS-CoV-2 Spike Protein
2021 · Viruses · 87 citations
https://doi.org/10.3390/v13030384
A SARS-CoV-2 antibody broadly neutralizes SARS-related coronaviruses and variants by coordinated recognition of a virus-vulnerable site
2021 · Immunity · 75 citations
https://doi.org/10.1016/j.immuni.2021.08.025
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat